単一細胞分析市場:製品別(消耗品、機器)、手法別(フローサイトメトリー、次世代シーケンス(NGS)、ポリメラーゼ連鎖反応(PCR)、質量分析、その他)、エンドユーザー別(学術・研究機関、バイオ・製薬会社、病院・診断研究所、その他)、アプリケーション別(腫瘍学、免疫学、神経学、幹細胞、非侵襲性出生前診断、体外受精(IVF)、その他)。世界の機会分析および産業予測、2021-2031年Single Cell Analysis Market By Product (Consumables, Instruments), By Techniques (Flow Cytometry, Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Mass Spectrometry, Others), By End User (Academic and Research Laboratories, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Others), By Application (Oncology, Immunology, Neurology, Stem cell, Non-Invasive Prenatal Diagnosis, In-Vitro Fertilization (IVF), Others): Global Opportunity Analysis and Industry Forecast, 2021-2031 世界の単一細胞解析市場は、2021年に26億4150万ドル、2031年には136億1676万ドルに達し、2022年から2031年にかけてCAGR17.8%を記録すると予測されています。 単一細胞解析(SCA)は、集団の不均一性を示し、関... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー世界の単一細胞解析市場は、2021年に26億4150万ドル、2031年には136億1676万ドルに達し、2022年から2031年にかけてCAGR17.8%を記録すると予測されています。単一細胞解析(SCA)は、集団の不均一性を示し、関心のある少数亜集団を特定し、個々の細胞の特定の形質について知るために不可欠である。マイクロ流体システムは、細胞の直径に近いスケールで動作するため、単一細胞の操作に有用である。高密度に充填されたマイクロウェル内に個々の細胞を迅速かつ決定論的にトラップすることができるマイクロ流体アレイ。このトラッピングアレイは、流速が可変の複数のマイクロ流体サンプル処理ユニットと連結することができ、様々な単一細胞研究に利用できる。なぜなら、単一細胞のトラッピング効率は流速ではなくチャンネル設計によって決定されるからである。SCAは、植物生物学、出生前診断、微生物学、免疫学、神経科学などでも一般的に使用されています。 世界の単一細胞分析市場の成長を促す主な要因としては、単一細胞分析における技術的進歩、製薬・バイオテクノロジー産業における研究開発の増加などが挙げられます。さらに、幹細胞研究の成長、個別化医療への注目の高まり、癌の有病率の急増が市場の成長をさらに後押ししています。しかし、単一細胞分析製品のコストが高いことが、予測期間中の単一細胞分析市場の成長を抑制すると予想されます。逆に、シングルセルシーケンスの高い成長ポテンシャルは、市場プレイヤーに有利な機会を提供すると予想されます。 単一細胞分析市場は、製品、アプリケーション、技術、エンドユーザー、地域に区分されます。製品別に見ると、市場は消耗品と機器に分類されます。アプリケーション別では、腫瘍学、免疫学、神経学、幹細胞、非侵襲的出生前診断、体外受精、その他に分類されます。技術別では、フローサイトメトリー、次世代シーケンシング、ポリメラーゼ連鎖反応、質量分析、その他に分類されます。エンドユーザー別では、学術・研究機関、バイオテクノロジー・製薬企業、病院・診断研究所、その他に分類されます。地域別では、北米、欧州、アジア太平洋、LAMEAで分析されています。 本レポートで紹介する主要企業は、Becton, Dickinson and Company, Danaher Corporation, Merck KGAA, QIAGEN N.V., Thermo Fisher Scientific, Inc, 10x Genomics, Illumina, Inc, Bio-Rad Laboratories, Agilent Technologies, Inc, Sartorius AG, Takara Holdingsinc, Oxford Nanopore Technologies, Berkley Light INC, BGI Genomics Co.Ltd., Diasorin Group, Dolomite Bio, Standard Biotools.他、多数。 ステークホルダーにとっての主なメリット 本レポートは、2021年から2031年までの単一細胞解析市場分析の市場セグメント、現在のトレンド、予測、ダイナミクスを定量的に分析し、単一細胞解析市場の優勢な機会を特定します。 ●市場調査は、主要な推進要因、阻害要因、機会に関連する情報とともに提供されます。 ポーターのファイブフォース分析により、買い手と供給者の潜在力を明らかにし、ステークホルダーが利益志向のビジネス決定を行い、供給者と買い手のネットワークを強化できるようにします。 単一細胞解析市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。 単一細胞解析市場の詳細な分析は、市場機会を決定するのに役立ちます。 市場プレイヤーのポジショニングは、ベンチマークを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。 地域別および世界別の単一細胞解析の市場動向、キープレイヤー、市場セグメント、アプリケーション分野、市場成長戦略などの分析が含まれています。 主な市場セグメント 製品別 消耗品 消耗品 ●装置 技術別 フローサイトメトリー 次世代シーケンサー(NGS) ポリメラーゼ連鎖反応(PCR) 質量分析計 その他 エンドユーザー別 学術・研究機関 バイオテクノロジー・製薬会社 病院・診断所 その他 アプリケーション別 オンコロジー 免疫学 神経領域 幹細胞 非侵襲的出生前診断 体外受精(IVF) その他 地域別 北米 米国 カナダ メキシコ 欧州 ドイツ フランス イギリス イタリア スペイン その他の地域 アジア・パシフィック 日本 中国 インド オーストラリア 韓国 その他のアジア太平洋地域 LAMEA ブラジル サウジアラビア 南アフリカ LAMEAの残りの地域 主な市場関係者 10x Genomics アジレント・テクノロジー ベクトン・ディッキンソン&カンパニー バイオ・ラッド・ラボラトリーズ Danaher Corporation (Cytiva Life Sciences) イルミナ社(Illumina, Inc. バークレーライト ○ BGI GENOMICS CO.LTD ディアソリングループ(ルミネクス株式会社) DOLOMITE BIO MERCK KGAA OXFORD NANAOPORE TECHNOLOGIES QIAGEN N.V Sartorius AG STANDARD BIOTOOLS (フルイディグム株式会社) タカラホールディングス サーモフィッシャーサイエンティフィック, INC. 目次CHAPTER 1:INTRODUCTION1.1.Report description 1.2.Key market segments 1.3.Key benefits to the stakeholders 1.4.Research Methodology 1.4.1.Secondary research 1.4.2.Primary research 1.4.3.Analyst tools and models CHAPTER 2:EXECUTIVE SUMMARY 2.1.Key findings of the study 2.2.CXO Perspective CHAPTER 3:MARKET OVERVIEW 3.1.Market definition and scope 3.2.Key findings 3.2.1.Top investment pockets 3.3.Porter’s five forces analysis 3.4.Top player positioning 3.5.Market dynamics 3.5.1.Drivers 3.5.2.Restraints 3.5.3.Opportunities 3.6.COVID-19 Impact Analysis on the market CHAPTER 4: SINGLE CELL ANALYSIS MARKET, BY PRODUCT 4.1 Overview 4.1.1 Market size and forecast 4.2 Consumables 4.2.1 Key market trends, growth factors and opportunities 4.2.2 Market size and forecast, by region 4.2.3 Market analysis by country 4.3 Instruments 4.3.1 Key market trends, growth factors and opportunities 4.3.2 Market size and forecast, by region 4.3.3 Market analysis by country CHAPTER 5: SINGLE CELL ANALYSIS MARKET, BY APPLICATION 5.1 Overview 5.1.1 Market size and forecast 5.2 Oncology 5.2.1 Key market trends, growth factors and opportunities 5.2.2 Market size and forecast, by region 5.2.3 Market analysis by country 5.3 Immunology 5.3.1 Key market trends, growth factors and opportunities 5.3.2 Market size and forecast, by region 5.3.3 Market analysis by country 5.4 Neurology 5.4.1 Key market trends, growth factors and opportunities 5.4.2 Market size and forecast, by region 5.4.3 Market analysis by country 5.5 Stem cell 5.5.1 Key market trends, growth factors and opportunities 5.5.2 Market size and forecast, by region 5.5.3 Market analysis by country 5.6 Non-Invasive Prenatal Diagnosis 5.6.1 Key market trends, growth factors and opportunities 5.6.2 Market size and forecast, by region 5.6.3 Market analysis by country 5.7 In-Vitro Fertilization (IVF) 5.7.1 Key market trends, growth factors and opportunities 5.7.2 Market size and forecast, by region 5.7.3 Market analysis by country 5.8 Others 5.8.1 Key market trends, growth factors and opportunities 5.8.2 Market size and forecast, by region 5.8.3 Market analysis by country CHAPTER 6: SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES 6.1 Overview 6.1.1 Market size and forecast 6.2 Flow Cytometry 6.2.1 Key market trends, growth factors and opportunities 6.2.2 Market size and forecast, by region 6.2.3 Market analysis by country 6.3 Next Generation Sequencing (NGS) 6.3.1 Key market trends, growth factors and opportunities 6.3.2 Market size and forecast, by region 6.3.3 Market analysis by country 6.4 Polymerase Chain Reaction (PCR) 6.4.1 Key market trends, growth factors and opportunities 6.4.2 Market size and forecast, by region 6.4.3 Market analysis by country 6.5 Mass Spectrometry 6.5.1 Key market trends, growth factors and opportunities 6.5.2 Market size and forecast, by region 6.5.3 Market analysis by country 6.6 Others 6.6.1 Key market trends, growth factors and opportunities 6.6.2 Market size and forecast, by region 6.6.3 Market analysis by country CHAPTER 7: SINGLE CELL ANALYSIS MARKET, BY END USER 7.1 Overview 7.1.1 Market size and forecast 7.2 Academic and Research Laboratories 7.2.1 Key market trends, growth factors and opportunities 7.2.2 Market size and forecast, by region 7.2.3 Market analysis by country 7.3 Biotechnology and Pharmaceutical Companies 7.3.1 Key market trends, growth factors and opportunities 7.3.2 Market size and forecast, by region 7.3.3 Market analysis by country 7.4 Hospitals and Diagnostic Laboratories 7.4.1 Key market trends, growth factors and opportunities 7.4.2 Market size and forecast, by region 7.4.3 Market analysis by country 7.5 Others 7.5.1 Key market trends, growth factors and opportunities 7.5.2 Market size and forecast, by region 7.5.3 Market analysis by country CHAPTER 8: SINGLE CELL ANALYSIS MARKET, BY REGION 8.1 Overview 8.1.1 Market size and forecast 8.2 North America 8.2.1 Key trends and opportunities 8.2.2 North America Market size and forecast, by Product 8.2.3 North America Market size and forecast, by Application 8.2.4 North America Market size and forecast, by Techniques 8.2.5 North America Market size and forecast, by End User 8.2.6 North America Market size and forecast, by country 8.2.6.1 U.S. 8.2.6.1.1 Market size and forecast, by Product 8.2.6.1.2 Market size and forecast, by Application 8.2.6.1.3 Market size and forecast, by Techniques 8.2.6.1.4 Market size and forecast, by End User 8.2.6.2 Canada 8.2.6.2.1 Market size and forecast, by Product 8.2.6.2.2 Market size and forecast, by Application 8.2.6.2.3 Market size and forecast, by Techniques 8.2.6.2.4 Market size and forecast, by End User 8.2.6.3 Mexico 8.2.6.3.1 Market size and forecast, by Product 8.2.6.3.2 Market size and forecast, by Application 8.2.6.3.3 Market size and forecast, by Techniques 8.2.6.3.4 Market size and forecast, by End User 8.3 Europe 8.3.1 Key trends and opportunities 8.3.2 Europe Market size and forecast, by Product 8.3.3 Europe Market size and forecast, by Application 8.3.4 Europe Market size and forecast, by Techniques 8.3.5 Europe Market size and forecast, by End User 8.3.6 Europe Market size and forecast, by country 8.3.6.1 Germany 8.3.6.1.1 Market size and forecast, by Product 8.3.6.1.2 Market size and forecast, by Application 8.3.6.1.3 Market size and forecast, by Techniques 8.3.6.1.4 Market size and forecast, by End User 8.3.6.2 France 8.3.6.2.1 Market size and forecast, by Product 8.3.6.2.2 Market size and forecast, by Application 8.3.6.2.3 Market size and forecast, by Techniques 8.3.6.2.4 Market size and forecast, by End User 8.3.6.3 U.K. 8.3.6.3.1 Market size and forecast, by Product 8.3.6.3.2 Market size and forecast, by Application 8.3.6.3.3 Market size and forecast, by Techniques 8.3.6.3.4 Market size and forecast, by End User 8.3.6.4 Italy 8.3.6.4.1 Market size and forecast, by Product 8.3.6.4.2 Market size and forecast, by Application 8.3.6.4.3 Market size and forecast, by Techniques 8.3.6.4.4 Market size and forecast, by End User 8.3.6.5 Spain 8.3.6.5.1 Market size and forecast, by Product 8.3.6.5.2 Market size and forecast, by Application 8.3.6.5.3 Market size and forecast, by Techniques 8.3.6.5.4 Market size and forecast, by End User 8.3.6.6 Rest of Europe 8.3.6.6.1 Market size and forecast, by Product 8.3.6.6.2 Market size and forecast, by Application 8.3.6.6.3 Market size and forecast, by Techniques 8.3.6.6.4 Market size and forecast, by End User 8.4 Asia-Pacific 8.4.1 Key trends and opportunities 8.4.2 Asia-Pacific Market size and forecast, by Product 8.4.3 Asia-Pacific Market size and forecast, by Application 8.4.4 Asia-Pacific Market size and forecast, by Techniques 8.4.5 Asia-Pacific Market size and forecast, by End User 8.4.6 Asia-Pacific Market size and forecast, by country 8.4.6.1 Japan 8.4.6.1.1 Market size and forecast, by Product 8.4.6.1.2 Market size and forecast, by Application 8.4.6.1.3 Market size and forecast, by Techniques 8.4.6.1.4 Market size and forecast, by End User 8.4.6.2 China 8.4.6.2.1 Market size and forecast, by Product 8.4.6.2.2 Market size and forecast, by Application 8.4.6.2.3 Market size and forecast, by Techniques 8.4.6.2.4 Market size and forecast, by End User 8.4.6.3 India 8.4.6.3.1 Market size and forecast, by Product 8.4.6.3.2 Market size and forecast, by Application 8.4.6.3.3 Market size and forecast, by Techniques 8.4.6.3.4 Market size and forecast, by End User 8.4.6.4 Australia 8.4.6.4.1 Market size and forecast, by Product 8.4.6.4.2 Market size and forecast, by Application 8.4.6.4.3 Market size and forecast, by Techniques 8.4.6.4.4 Market size and forecast, by End User 8.4.6.5 South Korea 8.4.6.5.1 Market size and forecast, by Product 8.4.6.5.2 Market size and forecast, by Application 8.4.6.5.3 Market size and forecast, by Techniques 8.4.6.5.4 Market size and forecast, by End User 8.4.6.6 Rest of Asia-Pacific 8.4.6.6.1 Market size and forecast, by Product 8.4.6.6.2 Market size and forecast, by Application 8.4.6.6.3 Market size and forecast, by Techniques 8.4.6.6.4 Market size and forecast, by End User 8.5 LAMEA 8.5.1 Key trends and opportunities 8.5.2 LAMEA Market size and forecast, by Product 8.5.3 LAMEA Market size and forecast, by Application 8.5.4 LAMEA Market size and forecast, by Techniques 8.5.5 LAMEA Market size and forecast, by End User 8.5.6 LAMEA Market size and forecast, by country 8.5.6.1 Brazil 8.5.6.1.1 Market size and forecast, by Product 8.5.6.1.2 Market size and forecast, by Application 8.5.6.1.3 Market size and forecast, by Techniques 8.5.6.1.4 Market size and forecast, by End User 8.5.6.2 Saudi Arabia 8.5.6.2.1 Market size and forecast, by Product 8.5.6.2.2 Market size and forecast, by Application 8.5.6.2.3 Market size and forecast, by Techniques 8.5.6.2.4 Market size and forecast, by End User 8.5.6.3 South Africa 8.5.6.3.1 Market size and forecast, by Product 8.5.6.3.2 Market size and forecast, by Application 8.5.6.3.3 Market size and forecast, by Techniques 8.5.6.3.4 Market size and forecast, by End User 8.5.6.4 Rest of LAMEA 8.5.6.4.1 Market size and forecast, by Product 8.5.6.4.2 Market size and forecast, by Application 8.5.6.4.3 Market size and forecast, by Techniques 8.5.6.4.4 Market size and forecast, by End User CHAPTER 9: COMPANY LANDSCAPE 9.1. Introduction 9.2. Top winning strategies 9.3. Product Mapping of Top 10 Player 9.4. Competitive Dashboard 9.5. Competitive Heatmap 9.6. Key developments CHAPTER 10: COMPANY PROFILES 10.1 10x Genomics 10.1.1 Company overview 10.1.2 Company snapshot 10.1.3 Operating business segments 10.1.4 Product portfolio 10.1.5 Business performance 10.1.6 Key strategic moves and developments 10.2 Agilent Technologies, Inc. 10.2.1 Company overview 10.2.2 Company snapshot 10.2.3 Operating business segments 10.2.4 Product portfolio 10.2.5 Business performance 10.2.6 Key strategic moves and developments 10.3 Becton, Dickinson and Company 10.3.1 Company overview 10.3.2 Company snapshot 10.3.3 Operating business segments 10.3.4 Product portfolio 10.3.5 Business performance 10.3.6 Key strategic moves and developments 10.4 Bio-Rad Laboratories 10.4.1 Company overview 10.4.2 Company snapshot 10.4.3 Operating business segments 10.4.4 Product portfolio 10.4.5 Business performance 10.4.6 Key strategic moves and developments 10.5 Danaher Corporation(Cytiva Life Sciences) 10.5.1 Company overview 10.5.2 Company snapshot 10.5.3 Operating business segments 10.5.4 Product portfolio 10.5.5 Business performance 10.5.6 Key strategic moves and developments 10.6 Illumina, Inc. 10.6.1 Company overview 10.6.2 Company snapshot 10.6.3 Operating business segments 10.6.4 Product portfolio 10.6.5 Business performance 10.6.6 Key strategic moves and developments 10.7 BERKLEY LIGHTS INC 10.7.1 Company overview 10.7.2 Company snapshot 10.7.3 Operating business segments 10.7.4 Product portfolio 10.7.5 Business performance 10.7.6 Key strategic moves and developments 10.8 BGI GENOMICS CO. LTD 10.8.1 Company overview 10.8.2 Company snapshot 10.8.3 Operating business segments 10.8.4 Product portfolio 10.8.5 Business performance 10.8.6 Key strategic moves and developments 10.9 DIASORIN GROUP (LUMINEX CORPORATION) 10.9.1 Company overview 10.9.2 Company snapshot 10.9.3 Operating business segments 10.9.4 Product portfolio 10.9.5 Business performance 10.9.6 Key strategic moves and developments 10.10 DOLOMITE BIO 10.10.1 Company overview 10.10.2 Company snapshot 10.10.3 Operating business segments 10.10.4 Product portfolio 10.10.5 Business performance 10.10.6 Key strategic moves and developments 10.11 MERCK KGAA 10.11.1 Company overview 10.11.2 Company snapshot 10.11.3 Operating business segments 10.11.4 Product portfolio 10.11.5 Business performance 10.11.6 Key strategic moves and developments 10.12 OXFORD NANAOPORE TECHNOLOGIES 10.12.1 Company overview 10.12.2 Company snapshot 10.12.3 Operating business segments 10.12.4 Product portfolio 10.12.5 Business performance 10.12.6 Key strategic moves and developments 10.13 QIAGEN N.V 10.13.1 Company overview 10.13.2 Company snapshot 10.13.3 Operating business segments 10.13.4 Product portfolio 10.13.5 Business performance 10.13.6 Key strategic moves and developments 10.14 Sartorius AG 10.14.1 Company overview 10.14.2 Company snapshot 10.14.3 Operating business segments 10.14.4 Product portfolio 10.14.5 Business performance 10.14.6 Key strategic moves and developments 10.15 STANDARD BIOTOOLS (Fluidigm Corporation) 10.15.1 Company overview 10.15.2 Company snapshot 10.15.3 Operating business segments 10.15.4 Product portfolio 10.15.5 Business performance 10.15.6 Key strategic moves and developments 10.16 TAKARA HOLDINGS INC 10.16.1 Company overview 10.16.2 Company snapshot 10.16.3 Operating business segments 10.16.4 Product portfolio 10.16.5 Business performance 10.16.6 Key strategic moves and developments 10.17 THERMO FISHER SCIENTIFIC, INC. 10.17.1 Company overview 10.17.2 Company snapshot 10.17.3 Operating business segments 10.17.4 Product portfolio 10.17.5 Business performance 10.17.6 Key strategic moves and developments
SummaryThe global single cell analysis market was valued at $2,641.5 million in 2021, and is projected to reach $13,616.76 million by 2031, registering a CAGR of 17.8% from 2022 to 2031. Table of ContentsCHAPTER 1:INTRODUCTION1.1.Report description 1.2.Key market segments 1.3.Key benefits to the stakeholders 1.4.Research Methodology 1.4.1.Secondary research 1.4.2.Primary research 1.4.3.Analyst tools and models CHAPTER 2:EXECUTIVE SUMMARY 2.1.Key findings of the study 2.2.CXO Perspective CHAPTER 3:MARKET OVERVIEW 3.1.Market definition and scope 3.2.Key findings 3.2.1.Top investment pockets 3.3.Porter’s five forces analysis 3.4.Top player positioning 3.5.Market dynamics 3.5.1.Drivers 3.5.2.Restraints 3.5.3.Opportunities 3.6.COVID-19 Impact Analysis on the market CHAPTER 4: SINGLE CELL ANALYSIS MARKET, BY PRODUCT 4.1 Overview 4.1.1 Market size and forecast 4.2 Consumables 4.2.1 Key market trends, growth factors and opportunities 4.2.2 Market size and forecast, by region 4.2.3 Market analysis by country 4.3 Instruments 4.3.1 Key market trends, growth factors and opportunities 4.3.2 Market size and forecast, by region 4.3.3 Market analysis by country CHAPTER 5: SINGLE CELL ANALYSIS MARKET, BY APPLICATION 5.1 Overview 5.1.1 Market size and forecast 5.2 Oncology 5.2.1 Key market trends, growth factors and opportunities 5.2.2 Market size and forecast, by region 5.2.3 Market analysis by country 5.3 Immunology 5.3.1 Key market trends, growth factors and opportunities 5.3.2 Market size and forecast, by region 5.3.3 Market analysis by country 5.4 Neurology 5.4.1 Key market trends, growth factors and opportunities 5.4.2 Market size and forecast, by region 5.4.3 Market analysis by country 5.5 Stem cell 5.5.1 Key market trends, growth factors and opportunities 5.5.2 Market size and forecast, by region 5.5.3 Market analysis by country 5.6 Non-Invasive Prenatal Diagnosis 5.6.1 Key market trends, growth factors and opportunities 5.6.2 Market size and forecast, by region 5.6.3 Market analysis by country 5.7 In-Vitro Fertilization (IVF) 5.7.1 Key market trends, growth factors and opportunities 5.7.2 Market size and forecast, by region 5.7.3 Market analysis by country 5.8 Others 5.8.1 Key market trends, growth factors and opportunities 5.8.2 Market size and forecast, by region 5.8.3 Market analysis by country CHAPTER 6: SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES 6.1 Overview 6.1.1 Market size and forecast 6.2 Flow Cytometry 6.2.1 Key market trends, growth factors and opportunities 6.2.2 Market size and forecast, by region 6.2.3 Market analysis by country 6.3 Next Generation Sequencing (NGS) 6.3.1 Key market trends, growth factors and opportunities 6.3.2 Market size and forecast, by region 6.3.3 Market analysis by country 6.4 Polymerase Chain Reaction (PCR) 6.4.1 Key market trends, growth factors and opportunities 6.4.2 Market size and forecast, by region 6.4.3 Market analysis by country 6.5 Mass Spectrometry 6.5.1 Key market trends, growth factors and opportunities 6.5.2 Market size and forecast, by region 6.5.3 Market analysis by country 6.6 Others 6.6.1 Key market trends, growth factors and opportunities 6.6.2 Market size and forecast, by region 6.6.3 Market analysis by country CHAPTER 7: SINGLE CELL ANALYSIS MARKET, BY END USER 7.1 Overview 7.1.1 Market size and forecast 7.2 Academic and Research Laboratories 7.2.1 Key market trends, growth factors and opportunities 7.2.2 Market size and forecast, by region 7.2.3 Market analysis by country 7.3 Biotechnology and Pharmaceutical Companies 7.3.1 Key market trends, growth factors and opportunities 7.3.2 Market size and forecast, by region 7.3.3 Market analysis by country 7.4 Hospitals and Diagnostic Laboratories 7.4.1 Key market trends, growth factors and opportunities 7.4.2 Market size and forecast, by region 7.4.3 Market analysis by country 7.5 Others 7.5.1 Key market trends, growth factors and opportunities 7.5.2 Market size and forecast, by region 7.5.3 Market analysis by country CHAPTER 8: SINGLE CELL ANALYSIS MARKET, BY REGION 8.1 Overview 8.1.1 Market size and forecast 8.2 North America 8.2.1 Key trends and opportunities 8.2.2 North America Market size and forecast, by Product 8.2.3 North America Market size and forecast, by Application 8.2.4 North America Market size and forecast, by Techniques 8.2.5 North America Market size and forecast, by End User 8.2.6 North America Market size and forecast, by country 8.2.6.1 U.S. 8.2.6.1.1 Market size and forecast, by Product 8.2.6.1.2 Market size and forecast, by Application 8.2.6.1.3 Market size and forecast, by Techniques 8.2.6.1.4 Market size and forecast, by End User 8.2.6.2 Canada 8.2.6.2.1 Market size and forecast, by Product 8.2.6.2.2 Market size and forecast, by Application 8.2.6.2.3 Market size and forecast, by Techniques 8.2.6.2.4 Market size and forecast, by End User 8.2.6.3 Mexico 8.2.6.3.1 Market size and forecast, by Product 8.2.6.3.2 Market size and forecast, by Application 8.2.6.3.3 Market size and forecast, by Techniques 8.2.6.3.4 Market size and forecast, by End User 8.3 Europe 8.3.1 Key trends and opportunities 8.3.2 Europe Market size and forecast, by Product 8.3.3 Europe Market size and forecast, by Application 8.3.4 Europe Market size and forecast, by Techniques 8.3.5 Europe Market size and forecast, by End User 8.3.6 Europe Market size and forecast, by country 8.3.6.1 Germany 8.3.6.1.1 Market size and forecast, by Product 8.3.6.1.2 Market size and forecast, by Application 8.3.6.1.3 Market size and forecast, by Techniques 8.3.6.1.4 Market size and forecast, by End User 8.3.6.2 France 8.3.6.2.1 Market size and forecast, by Product 8.3.6.2.2 Market size and forecast, by Application 8.3.6.2.3 Market size and forecast, by Techniques 8.3.6.2.4 Market size and forecast, by End User 8.3.6.3 U.K. 8.3.6.3.1 Market size and forecast, by Product 8.3.6.3.2 Market size and forecast, by Application 8.3.6.3.3 Market size and forecast, by Techniques 8.3.6.3.4 Market size and forecast, by End User 8.3.6.4 Italy 8.3.6.4.1 Market size and forecast, by Product 8.3.6.4.2 Market size and forecast, by Application 8.3.6.4.3 Market size and forecast, by Techniques 8.3.6.4.4 Market size and forecast, by End User 8.3.6.5 Spain 8.3.6.5.1 Market size and forecast, by Product 8.3.6.5.2 Market size and forecast, by Application 8.3.6.5.3 Market size and forecast, by Techniques 8.3.6.5.4 Market size and forecast, by End User 8.3.6.6 Rest of Europe 8.3.6.6.1 Market size and forecast, by Product 8.3.6.6.2 Market size and forecast, by Application 8.3.6.6.3 Market size and forecast, by Techniques 8.3.6.6.4 Market size and forecast, by End User 8.4 Asia-Pacific 8.4.1 Key trends and opportunities 8.4.2 Asia-Pacific Market size and forecast, by Product 8.4.3 Asia-Pacific Market size and forecast, by Application 8.4.4 Asia-Pacific Market size and forecast, by Techniques 8.4.5 Asia-Pacific Market size and forecast, by End User 8.4.6 Asia-Pacific Market size and forecast, by country 8.4.6.1 Japan 8.4.6.1.1 Market size and forecast, by Product 8.4.6.1.2 Market size and forecast, by Application 8.4.6.1.3 Market size and forecast, by Techniques 8.4.6.1.4 Market size and forecast, by End User 8.4.6.2 China 8.4.6.2.1 Market size and forecast, by Product 8.4.6.2.2 Market size and forecast, by Application 8.4.6.2.3 Market size and forecast, by Techniques 8.4.6.2.4 Market size and forecast, by End User 8.4.6.3 India 8.4.6.3.1 Market size and forecast, by Product 8.4.6.3.2 Market size and forecast, by Application 8.4.6.3.3 Market size and forecast, by Techniques 8.4.6.3.4 Market size and forecast, by End User 8.4.6.4 Australia 8.4.6.4.1 Market size and forecast, by Product 8.4.6.4.2 Market size and forecast, by Application 8.4.6.4.3 Market size and forecast, by Techniques 8.4.6.4.4 Market size and forecast, by End User 8.4.6.5 South Korea 8.4.6.5.1 Market size and forecast, by Product 8.4.6.5.2 Market size and forecast, by Application 8.4.6.5.3 Market size and forecast, by Techniques 8.4.6.5.4 Market size and forecast, by End User 8.4.6.6 Rest of Asia-Pacific 8.4.6.6.1 Market size and forecast, by Product 8.4.6.6.2 Market size and forecast, by Application 8.4.6.6.3 Market size and forecast, by Techniques 8.4.6.6.4 Market size and forecast, by End User 8.5 LAMEA 8.5.1 Key trends and opportunities 8.5.2 LAMEA Market size and forecast, by Product 8.5.3 LAMEA Market size and forecast, by Application 8.5.4 LAMEA Market size and forecast, by Techniques 8.5.5 LAMEA Market size and forecast, by End User 8.5.6 LAMEA Market size and forecast, by country 8.5.6.1 Brazil 8.5.6.1.1 Market size and forecast, by Product 8.5.6.1.2 Market size and forecast, by Application 8.5.6.1.3 Market size and forecast, by Techniques 8.5.6.1.4 Market size and forecast, by End User 8.5.6.2 Saudi Arabia 8.5.6.2.1 Market size and forecast, by Product 8.5.6.2.2 Market size and forecast, by Application 8.5.6.2.3 Market size and forecast, by Techniques 8.5.6.2.4 Market size and forecast, by End User 8.5.6.3 South Africa 8.5.6.3.1 Market size and forecast, by Product 8.5.6.3.2 Market size and forecast, by Application 8.5.6.3.3 Market size and forecast, by Techniques 8.5.6.3.4 Market size and forecast, by End User 8.5.6.4 Rest of LAMEA 8.5.6.4.1 Market size and forecast, by Product 8.5.6.4.2 Market size and forecast, by Application 8.5.6.4.3 Market size and forecast, by Techniques 8.5.6.4.4 Market size and forecast, by End User CHAPTER 9: COMPANY LANDSCAPE 9.1. Introduction 9.2. Top winning strategies 9.3. Product Mapping of Top 10 Player 9.4. Competitive Dashboard 9.5. Competitive Heatmap 9.6. Key developments CHAPTER 10: COMPANY PROFILES 10.1 10x Genomics 10.1.1 Company overview 10.1.2 Company snapshot 10.1.3 Operating business segments 10.1.4 Product portfolio 10.1.5 Business performance 10.1.6 Key strategic moves and developments 10.2 Agilent Technologies, Inc. 10.2.1 Company overview 10.2.2 Company snapshot 10.2.3 Operating business segments 10.2.4 Product portfolio 10.2.5 Business performance 10.2.6 Key strategic moves and developments 10.3 Becton, Dickinson and Company 10.3.1 Company overview 10.3.2 Company snapshot 10.3.3 Operating business segments 10.3.4 Product portfolio 10.3.5 Business performance 10.3.6 Key strategic moves and developments 10.4 Bio-Rad Laboratories 10.4.1 Company overview 10.4.2 Company snapshot 10.4.3 Operating business segments 10.4.4 Product portfolio 10.4.5 Business performance 10.4.6 Key strategic moves and developments 10.5 Danaher Corporation(Cytiva Life Sciences) 10.5.1 Company overview 10.5.2 Company snapshot 10.5.3 Operating business segments 10.5.4 Product portfolio 10.5.5 Business performance 10.5.6 Key strategic moves and developments 10.6 Illumina, Inc. 10.6.1 Company overview 10.6.2 Company snapshot 10.6.3 Operating business segments 10.6.4 Product portfolio 10.6.5 Business performance 10.6.6 Key strategic moves and developments 10.7 BERKLEY LIGHTS INC 10.7.1 Company overview 10.7.2 Company snapshot 10.7.3 Operating business segments 10.7.4 Product portfolio 10.7.5 Business performance 10.7.6 Key strategic moves and developments 10.8 BGI GENOMICS CO. LTD 10.8.1 Company overview 10.8.2 Company snapshot 10.8.3 Operating business segments 10.8.4 Product portfolio 10.8.5 Business performance 10.8.6 Key strategic moves and developments 10.9 DIASORIN GROUP (LUMINEX CORPORATION) 10.9.1 Company overview 10.9.2 Company snapshot 10.9.3 Operating business segments 10.9.4 Product portfolio 10.9.5 Business performance 10.9.6 Key strategic moves and developments 10.10 DOLOMITE BIO 10.10.1 Company overview 10.10.2 Company snapshot 10.10.3 Operating business segments 10.10.4 Product portfolio 10.10.5 Business performance 10.10.6 Key strategic moves and developments 10.11 MERCK KGAA 10.11.1 Company overview 10.11.2 Company snapshot 10.11.3 Operating business segments 10.11.4 Product portfolio 10.11.5 Business performance 10.11.6 Key strategic moves and developments 10.12 OXFORD NANAOPORE TECHNOLOGIES 10.12.1 Company overview 10.12.2 Company snapshot 10.12.3 Operating business segments 10.12.4 Product portfolio 10.12.5 Business performance 10.12.6 Key strategic moves and developments 10.13 QIAGEN N.V 10.13.1 Company overview 10.13.2 Company snapshot 10.13.3 Operating business segments 10.13.4 Product portfolio 10.13.5 Business performance 10.13.6 Key strategic moves and developments 10.14 Sartorius AG 10.14.1 Company overview 10.14.2 Company snapshot 10.14.3 Operating business segments 10.14.4 Product portfolio 10.14.5 Business performance 10.14.6 Key strategic moves and developments 10.15 STANDARD BIOTOOLS (Fluidigm Corporation) 10.15.1 Company overview 10.15.2 Company snapshot 10.15.3 Operating business segments 10.15.4 Product portfolio 10.15.5 Business performance 10.15.6 Key strategic moves and developments 10.16 TAKARA HOLDINGS INC 10.16.1 Company overview 10.16.2 Company snapshot 10.16.3 Operating business segments 10.16.4 Product portfolio 10.16.5 Business performance 10.16.6 Key strategic moves and developments 10.17 THERMO FISHER SCIENTIFIC, INC. 10.17.1 Company overview 10.17.2 Company snapshot 10.17.3 Operating business segments 10.17.4 Product portfolio 10.17.5 Business performance 10.17.6 Key strategic moves and developments
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(バイオ薬物)の最新刊レポート
Allied Market Research 社の最新刊レポート
本レポートと同じKEY WORD(biotechnology)の最新刊レポート
よくあるご質問Allied Market Research社はどのような調査会社ですか?アライドマーケットリサーチ(Allied Market Research)は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/07 10:27 155.63 円 167.26 円 203.27 円 |